NCT00646620View on ClinicalTrials.gov

Symbicort Onset of Action 1

PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

September 30, 2003

Conditions
Asthma
Interventions
DRUG

budesonide/formoterol (Symbicort)

DRUG

fluticasone/salmeterol (Advair Diskus)

DRUG

albuterol (Ventolin)

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY